Anavex Life Sciences Corp (AVXL)

[falconer66a]

Nature is fooled, too.

Another Alzheimer's drug, called blarcamesine - developed by Anavex Life Sciences in New York City - will continue to make its way through clinical trials. Blarcamesine activates a protein that improves the stability of neurons and their ability to connect with each other.

What? This bold statement by the people who run, publish Nature, one of the world's leading science journals? What could they have been thinking?

"Blarcamesine activates a protein that improves the stability of neurons and their ability to connect with each other."

If that's so, seems that it could be therapeutic for people with Alzheimer's. Their neurons are no longer stable and no longer connect well.

But, of course, the people at Nature didn't learn the blarcamesine truths the real experts detail in their posts here. Their inattention to the blarcamesine truths so clearly presented here compromises their publications' credibility. So sad.